← Open Payments lookup

FRANCES RIDENOUR: Open Payments

NPI 1528518339 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$731 in 19 payments from 12 companies in 2025. Trend: 2023 $416 · 2024 $786 · 2025 $731

Food & beverage: $731
CompanyPaymentsAmount
Lilly USA, LLC2$135
Corcept Therapeutics1$125
Novo Nordisk Inc1$125
AstraZeneca Pharmaceuticals LP5$120
Sumitomo Pharma America, Inc.1$71
GlaxoSmithKline, LLC.2$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Edwards Lifesciences Corporation1$14
VERTEX PHARMACEUTICALS INCORPORATED1$14

Products named: Korlym, KISUNLA, GEMTESA, FARXIGA, BREZTRI, TRELEGY ELLIPTA, CAPLYTA, RELISTOR.

Industry payments across TX — which companies pay providers there.